Intravenous thrombolysis for patients with in-hospital stroke onset: propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry

G. Tsivgoulis, A. H. Katsanos, P. Kadlecová, A. Czlonkowska, A. Kobayashi, M. Brozman, V. Švigelj, L. Csiba, K. Fekete, J. Kõrv, V. Demarin, A. Vilionskis, D. Jatuzis, Y. Krespi, T. Karapanayiotides, S. Giannopoulos, R. Mikulik

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Background and purpose: Recent cross-sectional study data suggest that intravenous thrombolysis (IVT) in patients with in-hospital stroke (IHS) onset is associated with unfavorable functional outcomes at hospital discharge and in-hospital mortality compared to patients with out-of-hospital stroke (OHS) onset treated with IVT. We sought to compare outcomes between IVT-treated patients with IHS and OHS by analysing propensity-score-matched data from the Safe Implementation of Treatments in Stroke-East registry. Methods: We compared the following outcomes for all propensity-score-matched patients: (i) symptomatic intracranial hemorrhage defined with the safe implementation of thrombolysis in stroke-monitoring study criteria, (ii) favorable functional outcome defined as a modified Rankin Scale (mRS) score of 0–1 at 3 months, (iii) functional independence defined as an mRS score of 0–2 at 3 months and (iv) 3-month mortality. Results: Out of a total of 19 077 IVT-treated patients with acute ischaemic stroke, 196 patients with IHS were matched to 5124 patients with OHS, with no differences in all baseline characteristics (P > 0.1). Patients with IHS had longer door-to-needle [90 (interquartile range, IQR, 60–140) vs. 65 (IQR, 47–95) min, P < 0.001] and door-to-imaging [40 (IQR, 20–90) vs. 24 (IQR, 15–35) min, P < 0.001] times compared with patients with OHS. No differences were detected in the rates of symptomatic intracranial hemorrhage (1.6% vs. 1.9%, P = 0.756), favorable functional outcome (46.4% vs. 42.3%, P = 0.257), functional independence (60.7% vs. 60.0%, P = 0.447) and mortality (14.3% vs. 15.1%, P = 0.764). The distribution of 3-month mRS scores was similar in the two groups (P = 0.273). Conclusions: Our findings underline the safety and efficacy of IVT for IHS. They also underscore the potential of reducing in-hospital delays for timely tissue plasminogen activator delivery in patients with IHS.

Original languageEnglish
Pages (from-to)1493-1498
Number of pages6
JournalEuropean Journal of Neurology
Volume24
Issue number12
DOIs
Publication statusPublished - Dec 1 2017

Fingerprint

Registries
Stroke
Therapeutics
Propensity Score
Intracranial Hemorrhages
Mortality
Tissue Plasminogen Activator
Hospital Mortality
Needles
Cross-Sectional Studies
Safety

Keywords

  • acute ischaemic stroke
  • door-to-needle time
  • in-hospital stroke
  • intravenous thrombolysis
  • onset-to-treatment time
  • stroke awareness

ASJC Scopus subject areas

  • Neurology
  • Clinical Neurology

Cite this

Intravenous thrombolysis for patients with in-hospital stroke onset : propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry. / Tsivgoulis, G.; Katsanos, A. H.; Kadlecová, P.; Czlonkowska, A.; Kobayashi, A.; Brozman, M.; Švigelj, V.; Csiba, L.; Fekete, K.; Kõrv, J.; Demarin, V.; Vilionskis, A.; Jatuzis, D.; Krespi, Y.; Karapanayiotides, T.; Giannopoulos, S.; Mikulik, R.

In: European Journal of Neurology, Vol. 24, No. 12, 01.12.2017, p. 1493-1498.

Research output: Contribution to journalArticle

Tsivgoulis, G, Katsanos, AH, Kadlecová, P, Czlonkowska, A, Kobayashi, A, Brozman, M, Švigelj, V, Csiba, L, Fekete, K, Kõrv, J, Demarin, V, Vilionskis, A, Jatuzis, D, Krespi, Y, Karapanayiotides, T, Giannopoulos, S & Mikulik, R 2017, 'Intravenous thrombolysis for patients with in-hospital stroke onset: propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry', European Journal of Neurology, vol. 24, no. 12, pp. 1493-1498. https://doi.org/10.1111/ene.13450
Tsivgoulis, G. ; Katsanos, A. H. ; Kadlecová, P. ; Czlonkowska, A. ; Kobayashi, A. ; Brozman, M. ; Švigelj, V. ; Csiba, L. ; Fekete, K. ; Kõrv, J. ; Demarin, V. ; Vilionskis, A. ; Jatuzis, D. ; Krespi, Y. ; Karapanayiotides, T. ; Giannopoulos, S. ; Mikulik, R. / Intravenous thrombolysis for patients with in-hospital stroke onset : propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry. In: European Journal of Neurology. 2017 ; Vol. 24, No. 12. pp. 1493-1498.
@article{9f07641423304197a85978d372fa702c,
title = "Intravenous thrombolysis for patients with in-hospital stroke onset: propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry",
abstract = "Background and purpose: Recent cross-sectional study data suggest that intravenous thrombolysis (IVT) in patients with in-hospital stroke (IHS) onset is associated with unfavorable functional outcomes at hospital discharge and in-hospital mortality compared to patients with out-of-hospital stroke (OHS) onset treated with IVT. We sought to compare outcomes between IVT-treated patients with IHS and OHS by analysing propensity-score-matched data from the Safe Implementation of Treatments in Stroke-East registry. Methods: We compared the following outcomes for all propensity-score-matched patients: (i) symptomatic intracranial hemorrhage defined with the safe implementation of thrombolysis in stroke-monitoring study criteria, (ii) favorable functional outcome defined as a modified Rankin Scale (mRS) score of 0–1 at 3 months, (iii) functional independence defined as an mRS score of 0–2 at 3 months and (iv) 3-month mortality. Results: Out of a total of 19 077 IVT-treated patients with acute ischaemic stroke, 196 patients with IHS were matched to 5124 patients with OHS, with no differences in all baseline characteristics (P > 0.1). Patients with IHS had longer door-to-needle [90 (interquartile range, IQR, 60–140) vs. 65 (IQR, 47–95) min, P < 0.001] and door-to-imaging [40 (IQR, 20–90) vs. 24 (IQR, 15–35) min, P < 0.001] times compared with patients with OHS. No differences were detected in the rates of symptomatic intracranial hemorrhage (1.6{\%} vs. 1.9{\%}, P = 0.756), favorable functional outcome (46.4{\%} vs. 42.3{\%}, P = 0.257), functional independence (60.7{\%} vs. 60.0{\%}, P = 0.447) and mortality (14.3{\%} vs. 15.1{\%}, P = 0.764). The distribution of 3-month mRS scores was similar in the two groups (P = 0.273). Conclusions: Our findings underline the safety and efficacy of IVT for IHS. They also underscore the potential of reducing in-hospital delays for timely tissue plasminogen activator delivery in patients with IHS.",
keywords = "acute ischaemic stroke, door-to-needle time, in-hospital stroke, intravenous thrombolysis, onset-to-treatment time, stroke awareness",
author = "G. Tsivgoulis and Katsanos, {A. H.} and P. Kadlecov{\'a} and A. Czlonkowska and A. Kobayashi and M. Brozman and V. Švigelj and L. Csiba and K. Fekete and J. K{\~o}rv and V. Demarin and A. Vilionskis and D. Jatuzis and Y. Krespi and T. Karapanayiotides and S. Giannopoulos and R. Mikulik",
year = "2017",
month = "12",
day = "1",
doi = "10.1111/ene.13450",
language = "English",
volume = "24",
pages = "1493--1498",
journal = "European Journal of Neurology",
issn = "1351-5101",
publisher = "Wiley-Blackwell",
number = "12",

}

TY - JOUR

T1 - Intravenous thrombolysis for patients with in-hospital stroke onset

T2 - propensity-matched analysis from the Safe Implementation of Treatments in Stroke-East registry

AU - Tsivgoulis, G.

AU - Katsanos, A. H.

AU - Kadlecová, P.

AU - Czlonkowska, A.

AU - Kobayashi, A.

AU - Brozman, M.

AU - Švigelj, V.

AU - Csiba, L.

AU - Fekete, K.

AU - Kõrv, J.

AU - Demarin, V.

AU - Vilionskis, A.

AU - Jatuzis, D.

AU - Krespi, Y.

AU - Karapanayiotides, T.

AU - Giannopoulos, S.

AU - Mikulik, R.

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Background and purpose: Recent cross-sectional study data suggest that intravenous thrombolysis (IVT) in patients with in-hospital stroke (IHS) onset is associated with unfavorable functional outcomes at hospital discharge and in-hospital mortality compared to patients with out-of-hospital stroke (OHS) onset treated with IVT. We sought to compare outcomes between IVT-treated patients with IHS and OHS by analysing propensity-score-matched data from the Safe Implementation of Treatments in Stroke-East registry. Methods: We compared the following outcomes for all propensity-score-matched patients: (i) symptomatic intracranial hemorrhage defined with the safe implementation of thrombolysis in stroke-monitoring study criteria, (ii) favorable functional outcome defined as a modified Rankin Scale (mRS) score of 0–1 at 3 months, (iii) functional independence defined as an mRS score of 0–2 at 3 months and (iv) 3-month mortality. Results: Out of a total of 19 077 IVT-treated patients with acute ischaemic stroke, 196 patients with IHS were matched to 5124 patients with OHS, with no differences in all baseline characteristics (P > 0.1). Patients with IHS had longer door-to-needle [90 (interquartile range, IQR, 60–140) vs. 65 (IQR, 47–95) min, P < 0.001] and door-to-imaging [40 (IQR, 20–90) vs. 24 (IQR, 15–35) min, P < 0.001] times compared with patients with OHS. No differences were detected in the rates of symptomatic intracranial hemorrhage (1.6% vs. 1.9%, P = 0.756), favorable functional outcome (46.4% vs. 42.3%, P = 0.257), functional independence (60.7% vs. 60.0%, P = 0.447) and mortality (14.3% vs. 15.1%, P = 0.764). The distribution of 3-month mRS scores was similar in the two groups (P = 0.273). Conclusions: Our findings underline the safety and efficacy of IVT for IHS. They also underscore the potential of reducing in-hospital delays for timely tissue plasminogen activator delivery in patients with IHS.

AB - Background and purpose: Recent cross-sectional study data suggest that intravenous thrombolysis (IVT) in patients with in-hospital stroke (IHS) onset is associated with unfavorable functional outcomes at hospital discharge and in-hospital mortality compared to patients with out-of-hospital stroke (OHS) onset treated with IVT. We sought to compare outcomes between IVT-treated patients with IHS and OHS by analysing propensity-score-matched data from the Safe Implementation of Treatments in Stroke-East registry. Methods: We compared the following outcomes for all propensity-score-matched patients: (i) symptomatic intracranial hemorrhage defined with the safe implementation of thrombolysis in stroke-monitoring study criteria, (ii) favorable functional outcome defined as a modified Rankin Scale (mRS) score of 0–1 at 3 months, (iii) functional independence defined as an mRS score of 0–2 at 3 months and (iv) 3-month mortality. Results: Out of a total of 19 077 IVT-treated patients with acute ischaemic stroke, 196 patients with IHS were matched to 5124 patients with OHS, with no differences in all baseline characteristics (P > 0.1). Patients with IHS had longer door-to-needle [90 (interquartile range, IQR, 60–140) vs. 65 (IQR, 47–95) min, P < 0.001] and door-to-imaging [40 (IQR, 20–90) vs. 24 (IQR, 15–35) min, P < 0.001] times compared with patients with OHS. No differences were detected in the rates of symptomatic intracranial hemorrhage (1.6% vs. 1.9%, P = 0.756), favorable functional outcome (46.4% vs. 42.3%, P = 0.257), functional independence (60.7% vs. 60.0%, P = 0.447) and mortality (14.3% vs. 15.1%, P = 0.764). The distribution of 3-month mRS scores was similar in the two groups (P = 0.273). Conclusions: Our findings underline the safety and efficacy of IVT for IHS. They also underscore the potential of reducing in-hospital delays for timely tissue plasminogen activator delivery in patients with IHS.

KW - acute ischaemic stroke

KW - door-to-needle time

KW - in-hospital stroke

KW - intravenous thrombolysis

KW - onset-to-treatment time

KW - stroke awareness

UR - http://www.scopus.com/inward/record.url?scp=85034075239&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85034075239&partnerID=8YFLogxK

U2 - 10.1111/ene.13450

DO - 10.1111/ene.13450

M3 - Article

C2 - 28888075

AN - SCOPUS:85034075239

VL - 24

SP - 1493

EP - 1498

JO - European Journal of Neurology

JF - European Journal of Neurology

SN - 1351-5101

IS - 12

ER -